Baus Medical (02609.HK): Adopting a stock reward plan for 2026.

Cnapp Finance News, BaiZe Medical (02609.HK) announced that the company has adopted the plan on June 23, 2026. The plan will be implemented using existing shares only, without issuing any new shares. The plan will be valid for ten years from the adoption date, with a maximum reward limit of 20 million shares. The trustee will purchase shares from the secondary market according to the instructions of the board of directors, in accordance with the plan rules and trust deeds to meet the exercise of rewards.